SLC5A2 and heart failure: The exact pathways of the direct cardioprotective effects of SGLT2 inhibitors remain to be fully elucidated but appear to involve various processes in the pathophysiology of heart failure, such as regulation of intracellular electrolytes, inflammation, oxidative stress, mitochondrial function, and autophagic flux [24, 86] (Fig. 2).